Cargando…

Impact of Elevated Levels of Dissolved CO(2) on Performance and Proteome Response of an Industrial 2′-Fucosyllactose Producing Escherichia coli Strain

Large-scale microbial industrial fermentations have significantly higher absolute pressure and dissolved CO(2) concentrations than otherwise comparable laboratory-scale processes. Yet the effect of increased dissolved CO(2) (dCO(2)) levels is rarely addressed in the literature. In the current work,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gecse, Greta, Vente, André, Kilstrup, Mogens, Becker, Peter, Johanson, Ted
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228177/ https://www.ncbi.nlm.nih.gov/pubmed/35744663 http://dx.doi.org/10.3390/microorganisms10061145

Ejemplares similares

Multi‐level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose
por: Li, Mengli, et al.
Publicado: (2022)

Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2(′)-fucosyllactose
por: Baumgärtner, Florian, et al.
Publicado: (2013)

Development of fluorescent Escherichia coli for a whole-cell sensor of 2ʹ-fucosyllactose
por: Shin, Jonghyeok, et al.
Publicado: (2020)

Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
por: Lee, Won-Heong, et al.
Publicado: (2012)

Metabolic engineering strategies of de novo pathway for enhancing 2′‐fucosyllactose synthesis in Escherichia coli
por: Li, Mengli, et al.
Publicado: (2021)

Multi-Path Optimization for Efficient Production of 2′-Fucosyllactose in an Engineered Escherichia coli C41 (DE3) Derivative
por: Ni, Zhijian, et al.
Publicado: (2020)

Safety of 2′‐fucosyllactose (2’‐FL) produced by a derivative strain (Escherichia coli SGR5) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2023)

Immunomodulatory and Prebiotic Effects of 2′-Fucosyllactose in Suckling Rats
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2019)

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697
por: Zabel, Bryan E., et al.
Publicado: (2020)

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula
por: Austin, Sean, et al.
Publicado: (2018)

Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice
por: Grabinger, Thomas, et al.
Publicado: (2019)

Engineered Bacillus subtilis for the de novo production of 2′-fucosyllactose
por: Zhang, Quanwei, et al.
Publicado: (2022)

Efficient production of 2′-fucosyllactose in unconventional yeast Yarrowia lipolytica
por: Zhang, Yan, et al.
Publicado: (2023)

Quantifying the human milk oligosaccharides 2’‐fucosyllactose and 3‐fucosyllactose in different food applications by high‐performance liquid chromatography with refractive index detection
por: Christensen, Anne Støvlbæk, et al.
Publicado: (2020)

Ovalbumin-Induced Epithelial Activation Directs Monocyte-Derived Dendritic Cells to Instruct Type 2 Inflammation in T Cells Which Is Differentially Modulated by 2′-Fucosyllactose and 3-Fucosyllactose
por: Zuurveld, Marit, et al.
Publicado: (2022)

Influence of 2′-fucosyllactose and galacto-oligosaccharides on the growth and adhesion of Streptococcus mutans
por: Salli, K., et al.
Publicado: (2020)

Fucoidan But Not 2′-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae
por: Tan, Malcolm Turk Hsern, et al.
Publicado: (2021)

Effects of Bifidobacterium with the Ability of 2′-Fucosyllactose Utilization on Intestinal Microecology of Mice
por: Mao, Bingyong, et al.
Publicado: (2022)

2-Fucosyllactose Metabolism by Bifidobacteria Promotes Lactobacilli Growth in Co-Culture
por: Nogacka, Alicja M., et al.
Publicado: (2023)

Oligofructose alone and in combination with 2′fucosyllactose induces physiologically relevant changes in γ-aminobutyric acid and organic acid production compared to sole 2′fucosyllactose supplementation: an in vitro study
por: Jackson, Peter Philip James, et al.
Publicado: (2023)

Safety of 3‐fucosyllactose (3‐FL) produced by a derivative strain of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2022)

Safety of 3‐fucosyllactose (3‐FL) produced by a derivative strain of Escherichia coli K‐12 DH1 as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2023)

2′-Fucosyllactose Increases the Abundance of Blautia in the Presence of Extracellular Fucosidase-Possessing Bacteria
por: Horigome, Ayako, et al.
Publicado: (2022)

Effect of Rotavirus Infection and 2′-Fucosyllactose Administration on Rat Intestinal Gene Expression
por: Sáez-Fuertes, Laura, et al.
Publicado: (2023)

Quantitative analysis of the Escherichia coli proteome
por: Wiśniewski, Jacek R., et al.
Publicado: (2014)

Proteomic alterations of Escherichia coli by paraquat
por: Isarankura-Na-Ayudhya, Patcharee, et al.
Publicado: (2010)

The functional proteome landscape of Escherichia coli
por: Mateus, André, et al.
Publicado: (2020)

The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
por: Wang, Yuanyifei, et al.
Publicado: (2020)

2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome
por: Kim, Yeon-Ji, et al.
Publicado: (2023)

Escherichia coli avoids high dissolved oxygen stress by activation of SoxRS and manganese-superoxide dismutase
por: Baez, Antonino, et al.
Publicado: (2013)

Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae
por: Yu, Sora, et al.
Publicado: (2018)

Metabolic Fate and Distribution of 2´‐Fucosyllactose: Direct Influence on Gut Microbial Activity but not on Brain
por: Kuntz, Sabine, et al.
Publicado: (2019)

Human Milk Oligosaccharide 2′-Fucosyllactose Induces Neuroprotection from Intracerebral Hemorrhage Stroke
por: Hung, Tsai-Wei, et al.
Publicado: (2021)

Screening of Bifidobacteria with Probiotic Potential from Healthy Infant Feces by Using 2′-Fucosyllactose
por: Zhang, Gongsheng, et al.
Publicado: (2023)

Signature of Pareto optimization in the Escherichia coli proteome
por: Koçillari, Loren, et al.
Publicado: (2018)

The quantitative and condition-dependent Escherichia coli proteome
por: Schmidt, Alexander, et al.
Publicado: (2015)

Effect of spaceflight on the phenotype and proteome of Escherichia coli
por: Liu, Yu, et al.
Publicado: (2023)

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
por: Vandenplas, Yvan, et al.
Publicado: (2018)

2′-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression
por: Yao, Qianqian, et al.
Publicado: (2022)

Poly(2-propyl-2-oxazoline)s in Aqueous Methanol: To Dissolve or not to Dissolve
por: Pooch, Fabian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_57bjfkvjklmloo9f5g1epmb6i3